Pantoprazole in Cisplatin Nephrotoxicity

Phase 3RecruitingNCT04217512

Sherief Abd-Elsalam60 enrolled

Overview

Pantoprazole in Cisplatin NephrotoxicityPantoprazole in Cisplatin Nephrotoxicity. Is it protective?

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Enrollment

Pantoprazole 0.6 mg/kg

Pantoprazole 1.6 mg\\kg

Standard hydration alone

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with head and neck cancer Exclusion Criteria: * GFR less than 59. * DM * Elevated liver enzymes more than 3 fold.

Sherief Abd-Elsalam

Tanta, Egypt

RECRUITING

Number of patients with no renal toxicity

The number of patients with no renal toxicity

Time frame: 6 months

Sherief Abd-Elsalam, ass. prof.

CONTACT

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.